Page last updated: 2024-12-05

propyl gallate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Propyl gallate is an organic compound with the formula C10H12O5. It is a white or slightly yellowish crystalline powder with a faint odor. It is a synthetic antioxidant used as a food additive to prevent rancidity and as a stabilizer in various pharmaceutical and industrial products. Propyl gallate is synthesized from gallic acid and propanol. It is studied for its antioxidant, anti-inflammatory, and anticancer properties. Research suggests that propyl gallate may protect against oxidative stress and inflammatory responses. It is also being investigated for its potential to inhibit the growth of cancer cells. Propyl gallate is widely used as a food additive due to its effectiveness in preventing the oxidation of fats and oils. Its importance lies in its ability to extend the shelf life of food products and maintain their quality. However, there are some concerns regarding its potential adverse effects on human health. Some studies have reported that propyl gallate may be associated with increased risk of certain cancers. Further research is needed to fully understand its safety profile. '

Propyl Gallate: Antioxidant for foods, fats, oils, ethers, emulsions, waxes, and transformer oils. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID4947
CHEMBL ID7983
CHEBI ID10607
SCHEMBL ID22630
MeSH IDM0017779

Synonyms (128)

Synonym
EU-0036319
BIDD:ER0334
3,4,5-trihydroxy-benzoic acid propyl ester
bdbm50032154
gallic acid, propyl ester
nipagallin p
nipa 49
tenox pg
n-propyl 3,5-trihydroxybenzoate
wln: qr bq cq evo3
n-propyl ester of 3,5-trihydroxybenzoic acid
propyl 3,5-trihydroxybenzoate
3,5-trihydroxybenzene-1-propylcarboxylate
nsc-2626
nsc2626
nci-c50588
benzoic acid,4,5-trihydroxy-, propyl ester
3,5-trihydroxybenzoic acid, propyl ester
progallin p
NCI60_002094
OPREA1_580415
CBDIVE_013134
propyl 3,4,5-trihydroxybenzoate
gallate, propyl
gallic acid propyl ester
einecs 204-498-2
hsdb 591
nci-c505888
3,4,5-trihydroxybenzoic acid n-propyl ester
n-propyl 3,4,5-trihydroxybenzoate
propylester kyseliny gallove [czech]
fema no. 2947
3,4,5-trihydroxybenzoic acid, propyl ester
n-propyl ester of 3,4,5-trihydroxybenzoic acid
nsc 2626
3,4,5-trihydroxybenzene-1-propylcarboxylate
ccris 541
3,4,5-trihydroxybenzoic acid propyl ester
ai3-17136
pro gallin p
n-propyl gallate
propyl gallate
121-79-9
nipanox s 1
benzoic acid, 3,4,5-trihydroxy-, propyl ester
inchi=1/c10h12o5/c1-2-3-15-10(14)6-4-7(11)9(13)8(12)5-6/h4-5,11-13h,2-3h2,1h
propyl gallate, >=98%, fcc
propyl gallate, powder
D02382
propyl gallate (nf)
NCGC00164234-01
gallic acid, n-propyl ester
AC-11365
EFFF5FFA-651C-4DE3-A25F-D807C65D5537
n-propyl-3,4,5-trihydroxybenzoate
anhydrous propyl gallate (e 310)
propyl gallate (e 310)
e-310
CHEMBL7983 ,
chebi:10607 ,
ins-310
e310
ins no.310
G0018
l ester
A19435
AKOS001603853
NCGC00164234-03
NCGC00164234-02
8d4snn7v92 ,
propyl gallate [nf]
propylester kyseliny gallove
unii-8d4snn7v92
tox21_202286
NCGC00259835-01
dtxcid901201
cas-121-79-9
dtxsid5021201 ,
tox21_113531
NCGC00254138-01
tox21_300060
FT-0626599
propyl gallate [fcc]
propyl gallate [inci]
n-propyl ester of 3,4,5- trihydroxybenzoic acid
propyl gallate [hsdb]
propyl gallate [fhfi]
propyl gallate [ii]
propyl gallate [vandf]
propyl gallate [mi]
propyl gallate [mart.]
propyl gallate [who-dd]
propyl gallate [ep monograph]
propyl gallate [usp-rs]
S5113
CCG-207932
SCHEMBL22630
NCGC00164234-04
gallic acid n-propyl ester
Q-201634
AC-34485
mfcd00002196
SR-01000944710-1
sr-01000944710
propyl gallate, for microscopy, >=98.0% (hplc)
propyl gallate, antioxidant, >=98.0% (hplc)
propyl gallate, united states pharmacopeia (usp) reference standard
propyl gallate, 98%
propyl gallate, pharmaceutical secondary standard; certified reference material
propyl gallate, usp, 98.0-102.0%
propyl gallate, european pharmacopoeia (ep) reference standard
gallic acid-propyl ester
propyl galiate
fema 2947
n-propyl-gallate
sustane pg
DB12450
Q608726
HY-N0524
propylgallate,(s)
AS-11986
BCP13340
gallic acid propyl esterz
CS-0009059
5-methyl-4,5-dihydrothiazole-2-thiol
propyl gallate, nf
E80666
3,4,5-trihydroxy-benzoic acid propy

Research Excerpts

Overview

Propyl gallate (PG) is a synthetic phenolic compound that possess a potent anti-oxidant and anti-inflammatory activities. n-Propyl Gallate (nPG) is a syntheticphenolic antioxidant with potential anti- inflammatory effects.

ExcerptReferenceRelevance
"Propyl gallate (PG) is an essential synthetic preservative that commonly used in food, cosmetics, and pharmacies as an antioxidant."( Pharmacokinetic and toxicological overview of propyl gallate food additive.
Alizadeh, AM; Dehghan, P; Ezzati Nazhad Dolatabadi, J; Javaheri-Ghezeldizaj, F, 2023
)
1.89
"Propyl gallate (PG) is a commonly used synthetic phenolic antioxidant in foodstuffs and industrial products. "( Ce(IV)-coordinated organogel-based assay for on-site monitoring of propyl gallate with turn-on fluorescence signal.
Dong, B; Liu, S; Mao, Y; Qu, H; Yao, L; Zheng, L, 2023
)
2.59
"Propyl gallate (PG) is a chemical compound obtained by esterification of propanol with gallic acid. "( Immunofluorescence evaluation of 4-hydroxynonenal and 8-hydroxy-2-deoxyguanosine activation in zebrafish (Daino rerio) larvae brain exposed (microinjected) to propyl gallate.
Atamanalp, M; Baran, A; Ceyhun, SB; Çomakli, S; Köktürk, M; Özkaraca, M; Parlak, V; Sağlam, YS; Topal, A, 2017
)
2.09
"Propyl gallate (PG) is an antioxidant substance widely used in cosmetics, pharmaceutical and food industries. "( Determination of developmental toxicity of zebrafish exposed to propyl gallate dosed lower than ADI (Acceptable Daily Intake).
Atamanalp, M; Baran, A; Ceyhun, SB; Köktürk, M, 2018
)
2.16
"Propyl gallate (PG) is a synthetic phenolic compound that possess a potent anti-oxidant and anti-inflammatory activities."( Propyl gallate sensitizes human lung cancer cells to cisplatin-induced apoptosis by targeting heme oxygenase-1 for TRC8-mediated degradation.
Jo, EJ; Kim, BC; Park, SJ, 2016
)
2.6
"n-Propyl gallate is a synthetic phenolic antioxidant with potential anti-inflammatory effects. "( n-Propyl gallate suppresses lipopolysaccharide-induced inducible nitric oxide synthase activation through protein kinase Cδ-mediated up-regulation of heme oxygenase-1 in RAW264.7 macrophages.
Jeon, W; Kim, BC; Park, SJ, 2017
)
1.9
"Propyl gallate (PG) is a synthetic antioxidant that has been used in processed food and medicinal preparations. "( Role of redox signaling regulation in propyl gallate-induced apoptosis of human leukemia cells.
Chen, CH; Kuo, CN; Lin, WC; Lu, FJ, 2011
)
2.08
"Propyl gallate is a potential novel therapeutic agent on prevention of diabetic nephropathy."( Propyl gallate plays a nephroprotective role in early stage of diabetic nephropathy associated with suppression of glomerular endothelial cell proliferation and angiogenesis.
Gan, Y; Li, J; Liu, H; Shen, J; Tang, J; Tian, S; Wang, L, 2012
)
2.54
"Propyl gallate (PG) is an antioxidant widely used in processed foods, cosmetics and medicinal preparations."( Apoptotic effect of propyl gallate in activated rat hepatic stellate cells.
Che, XH; Jiang, WY; Lee, SH; Parajuli, DR; Sohn, DH; Zhao, YZ, 2012
)
1.42
"n-Propyl gallate (nPG) is a food preservative that is generally regarded as safe by the US FDA. "( Propyl gallate is a superoxide dismutase mimic and protects cultured lens epithelial cells from H2O2 insult.
Chang, JS; Dziedzic, DC; Giblin, FJ; Leverenz, VR; Misra, IC; Padgaonkar, V; Pena, JT; Reddan, JR; Sevilla, M, 2003
)
2.48
"Propyl gallate (PG) is a platelet agonist characterized by inducing platelet aggregation, protein tyrosine phosphorylation, and platelet factor 3 activity. "( Effects of platelet inhibitors on propyl gallate-induced platelet aggregation, protein tyrosine phosphorylation, and platelet factor 3 activation.
Jackson, V; Kovics, R; Remick, DG; Xiao, H, 2004
)
2.05
"Propyl gallate is a synthetic platelet activator with the property to stimulate platelet aggregation."( Propyl gallate-induced platelet aggregation in patients with end-stage renal disease: the influence of the haemodialysis procedure.
Antoniadi, G; Barboutis, K; Eleftheriadis, T; Liakopoulos, V; Stefanidis, I; Tsiandoulas, A, 2006
)
2.5
"Propyl gallate is an antioxidant widely used in foods, cosmetics and pharmaceuticals. "( Ecotoxicological effects of the antioxidant additive propyl gallate in five aquatic systems.
del Peso, A; Jos, A; López-Artíguez, M; Repetto, G; Salguero, M; Zurita, JL, 2007
)
2.03
"Propyl Gallate is a generally recognized as safe (GRAS) antioxidant to protect fats, oils, and fat-containing food from rancidity that results from the formation of peroxides."( Final report on the amended safety assessment of Propyl Gallate.
, 2007
)
1.32
"Propyl gallate is a more potent suppressor of food intake than gallic acid."( Modes of action of gallic acid in suppressing food intake of rats.
Glick, Z, 1981
)
0.98

Effects

Propyl gallate (PG) has an anti-growth effect in lung cancer cells. PG has a high sensitizing potential; however, the frequency of allergic contact dermatitis from antioxidants was previously thought to be surprisingly low.

ExcerptReferenceRelevance
"Propyl gallate (PG) has an anti-growth effect in lung cancer cells. "( Enhanced cell death effects of MAP kinase inhibitors in propyl gallate-treated lung cancer cells are related to increased ROS levels and GSH depletion.
Park, WH, 2021
)
2.31
"Propyl gallate has a high sensitizing potential; however, the frequency of allergic contact dermatitis from antioxidants of the gallate type was previously thought to be surprisingly low."( Positive rates to propyl gallate on patch testing: a change in trend.
Basketter, DA; McFadden, J; Perez, A; White, IR, 2008
)
1.4
"Propyl gallate (PG) has an anti-growth effect in lung cancer cells. "( Enhanced cell death effects of MAP kinase inhibitors in propyl gallate-treated lung cancer cells are related to increased ROS levels and GSH depletion.
Park, WH, 2021
)
2.31
"Propyl gallate has a high sensitizing potential; however, the frequency of allergic contact dermatitis from antioxidants of the gallate type was previously thought to be surprisingly low."( Positive rates to propyl gallate on patch testing: a change in trend.
Basketter, DA; McFadden, J; Perez, A; White, IR, 2008
)
1.4

Treatment

Treatment with propyl gallate (PG) restored eNOS activity, ameliorated oxidative stress and improved glomerular pathological changes. PG also had a similar inhibitory effect on accumulation of phenolic acid, total flavonoids and lignin.

ExcerptReferenceRelevance
"Treatment with propyl gallate restored eNOS activity, ameliorated oxidative stress and improved glomerular pathological changes, but did not alter eNOS and VEGF expressions."( Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate.
Deng, Y; Gan, Y; Li, J; Liu, D; Liu, H; Liu, T; Shen, J; Tian, S; Wang, L; Wang, W; Ye, T,
)
0.69
"Treatment with propyl gallate (PG), another inhibitor of AOX, also had a similar inhibitory effect on accumulation of phenolic acid, total flavonoids and lignin."( Alternative oxidase (AOX) and phenolic metabolism in methyl jasmonate-treated hairy root cultures of Daucus carota L.
Arnholdt-Schmitt, B; Cardoso, HG; Mitra, A; Mukherjee, C; Sircar, D, 2012
)
0.72
"Treatment with propyl gallate improved glomerular pathological changes, reduced endothelial cell proliferation, decreased albuminuria, and restored eNOS activity, but did not alter eNOS expression."( Propyl gallate plays a nephroprotective role in early stage of diabetic nephropathy associated with suppression of glomerular endothelial cell proliferation and angiogenesis.
Gan, Y; Li, J; Liu, H; Shen, J; Tang, J; Tian, S; Wang, L, 2012
)
2.16

Toxicity

ExcerptReferenceRelevance
" In isolated perfused livers from fasted rats, sodium orthovanadate (2 mmol/l) led to toxic responses including reduction of oxygen consumption, release of cytosolic (glutamate-pyruvate-transaminase (GPT) and lactate dehydrogenase (LDH)) and mitochondrial (glutamate-dehydrogenase (GLDH)) enzymes, intracellular accumulation of calcium, a marked depletion of glutathione (GSH) and an enhanced formation and release of thiobarbituric acid- (TBA) reactive material."( Effect of antioxidants on vanadate-induced toxicity towards isolated perfused rat livers.
Kayser, E; Strubelt, O; Younes, M, 1991
)
0.28
" In the comparative toxic effects of PG and related gallates at concentration of 1 mM, octyl gallate (OG), dodecyl gallate (DG) and butyl gallate (BG) elicited an abrupt depletion of ATP, followed by an acute cell death."( Cytotoxicity of propyl gallate and related compounds in rat hepatocytes.
Nakagawa, Y; Tayama, S, 1995
)
0.64
" In comparisons of the toxic effects of PG and its metabolites at concentrations of 2 mM, the parent compound PG was the most toxic."( Metabolism and cytotoxicity of propyl gallate in isolated rat hepatocytes: effects of a thiol reductant and an esterase inhibitor.
Moldéus, P; Nakagawa, Y; Nakajima, K; Tayama, S, 1995
)
0.58
" In contrast to arachidonic acid, oleic acid was not toxic to the Hep G2-MV2E1-9 cells."( Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P4502E1.
Cederbaum, AI; Chen, Q; Galleano, M, 1997
)
0.3
" Propyl Gallate is a generally recognized as safe (GRAS) antioxidant to protect fats, oils, and fat-containing food from rancidity that results from the formation of peroxides."( Final report on the amended safety assessment of Propyl Gallate.
, 2007
)
1.5
" The aim of this study was to evaluate the potential toxic effect of PG injected to zebrafish embryos."( Determination of developmental toxicity of zebrafish exposed to propyl gallate dosed lower than ADI (Acceptable Daily Intake).
Atamanalp, M; Baran, A; Ceyhun, SB; Köktürk, M, 2018
)
0.72

Pharmacokinetics

ExcerptReferenceRelevance
" Pharmacokinetic parameters of BHA estimated in mice correlated with those reported for other species, including humans ("Interspecies Scaling"), suggesting that exposures are proportional to body weight across species."( Influence of dosing vehicles on the preclinical pharmacokinetics of phenolic antioxidants.
Erow, K; Montague, M; Penn, M; Vora, J; Wu, Z, 1999
)
0.3

Compound-Compound Interactions

ExcerptReferenceRelevance
"The antioxidant propyl gallate (PG) induced lipid peroxidation in combination with non-toxic Cu(II) concentrations in human fibroblasts."( Induction of lipid peroxidation in human fibroblasts by the antioxidant propyl gallate in combination with copper(II).
Hinrichsen, ML; Jacobi, H; Wess, D; Witte, I, 1999
)
0.88

Bioavailability

ExcerptReferenceRelevance
" The absolute oral bioavailability of PG (administered as an HPB complex) in rats was low (5%) suggesting extensive metabolism or incomplete absorption."( Influence of dosing vehicles on the preclinical pharmacokinetics of phenolic antioxidants.
Erow, K; Montague, M; Penn, M; Vora, J; Wu, Z, 1999
)
0.3
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" A combination of sodium chenodeoxycholate and propyl gallate was used to enhance bioavailability of MEDI7219 at the site of maximal gastrointestinal absorption, targeted by enteric-coated tablets."( Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease.
Balic, K; Grimsby, J; Huang, Y; Konkar, A; Liang, L; Naylor, J; Patel, C; Pechenov, S; Revell, J; Rosenbaum, AI; Subramony, JA; Tseng, L; Tyagi, P; Will, S, 2021
)
0.88
"Drug formulations such as spray drying are often required to improve the physicochemical properties and bioavailability of hydrophobic drugs."( Oxidative degradation in pharmaceuticals: Mechanism and stabilization of a spray-dried amorphous drug - A case study.
Kotha, RR; Kumar, A; Yehl, P; Zhang, K, 2022
)
0.72

Dosage Studied

ExcerptRelevanceReference
" The aim of this study was to compare the pharmacokinetics of BHA and PG in mice following dosing in either a "control" dosing vehicle (ethanol-saline, 2:3) or a solution of an inclusion complex of each agent with hydroxypropyl-beta-cyclodextrin (HPB) in saline."( Influence of dosing vehicles on the preclinical pharmacokinetics of phenolic antioxidants.
Erow, K; Montague, M; Penn, M; Vora, J; Wu, Z, 1999
)
0.3
" Then it is compared with the HPLC method in dosage of cosmetics and organic reagents, runtime, cost per analysis and LOD."( Quantitative determination of butylated hydroxyanisole and n-propyl gallate in cosmetics using three-dimensional fluorescence coupled with second-order calibration.
Chen, Y; Qing, XD; Wang, JY; Wu, HL; Yu, RQ; Zhai, M, 2013
)
0.63
" The SPR analysis showed dose-response sensograms of BSA upon increasing concentration of PG and TBHQ."( Kinetic studies of bovine serum albumin interaction with PG and TBHQ using surface plasmon resonance.
Ezzati Nazhad Dolatanbadi, J; Fathi, F; Omidi, Y; Rashidi, MR, 2016
)
0.43
" Non-monotonic dose-response curves were obtained for BuPB (in both assays) and PG (in the luciferase assay), respectively."( Estrogenic and anti-estrogenic activity of butylparaben, butylated hydroxyanisole, butylated hydroxytoluene and propyl gallate and their binary mixtures on two estrogen responsive cell lines (T47D-Kbluc, MCF-7).
Cherfan, J; Drugan, T; Gutleb, AC; Kiss, B; Loghin, F; Lupu, D; Pop, A, 2018
)
0.69
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (327 Product(s))

Product Categories

Product CategoryProducts
Other188
Condiments, Sauces, Groceries4
Snacks, Sweet snacks, Confectioneries2
Plant-based foods and beverages, Plant-based foods, Fruits and vegetables based foods, Fruits based foods, Fruits, Tropical fruits, Bananas2
Canned foods, Meals, Soups, Canned meals, Canned soups1
Snacks, Snacks sucrés, Confiseries, Produits de la ruche, Bonbons, Bonbons au miel1
Viandes et dérivés, Charcuteries, Saucisses1
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Petit-déjeuners, Céréales et pommes de terre, Céréales et dérivés, Céréales pour petit-déjeuner, Flocons, Flocons de céréales, Céréales extrudées, Flocons extrudés, Corn-flakes1
Snacks, Sweet snacks, Cocoa and its products, Confectioneries, Chocolate candies2
Mexican Dinner Mixes1
Landwirtschaftliche Produkte, Vogeleier, Hühnereier1
Salted snacks1
Compléments alimentaires, Compléments pour le Bodybuilding, Protéines en poudre1
Plant-based foods and beverages, Plant-based foods, Fruits and vegetables based foods, Vegetables based foods, Tomatoes and their products, Tomatoes1
Imbiss, Süßer Snack, Süßwaren, Kaugummis1
Snacks, Snacks sucrés, Biscuits et gâteaux, Gâteaux, Madeleines1
Sweeteners, Syrups, Simple syrups, Maple syrups1
Petit-déjeuners, Produits à tartiner, Produits à tartiner sucrés, Produits de la ruche, Produits d'élevages, Édulcorants, Miels, Miels français1
Dietary supplements1
Meats and their products, Meats, Prepared meats, Sausages1
Aides culinaires, Aides à la pâtisserie1
Meats and their products, Meals, Pizzas pies and quiches, Salted pies, Meat pies, Pork pies1
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Aliments à base de fruits et de légumes, Fruits et produits dérivés, Produits déshydratés, Fruits, Aliments à base de plantes séchées, Fruits secs, Fruits français, Pruneaux, Pruneaux d1
Viandes et dérivés, Viandes, Charcuteries, Saucissons, Saucissons secs1
Getränke, Wasser, Quellwasser, Mineralwasser, Natürliches Mineralwasser2
Tartes sucrées,Tartes aux pommes1
en:candies1
Gluten,free vermicelli.1
Viandes et dérivés, Viande de bœuf et dérivés, Viandes, Bœuf1
Dairies, Milks, Whole milks1
Desserts, Schokoladendesserts, Mousses au chocolat1
Plant-based foods and beverages, Plant-based foods, Fruits and vegetables based foods, Vegetables based foods, Mushrooms and their products, Mushrooms, Champignon mushrooms, Sliced champignon mushrooms1
Vegetarische-streichcreme1
Meats and their products, Beef and its products, Meat preparations, Meats, Beef, Beef preparations, Dried meats, Bresaola, italian meat products1
Postres, en:Puddings, Arroz con leche1
Milchprodukte, Fermentierte Lebensmittel, Desserts, Fermentierte Milch, Milchnachspeisen, en:Fermented dairy desserts, Joghurt, Schokoladenjoghurte1
Meats and their products, Meats, Prepared meats, Poultries, Turkey and its products, Turkeys, fr:Charcuteries cuites, Cooked-poultry-breast-slices, Cooked turkey breast slices, Turkey breasts1
Pflanzliche Lebensmittel und Getränke, Pflanzliche Lebensmittel, Getreide und Kartoffeln, Getreideprodukte, Mehle, Getreidemehle, Weizenmehle, Dinkelmehle, Dinkelmehle Type 6301
Pflanzliche Lebensmittel und Getränke, Pflanzliche Lebensmittel, Mehle, Dinkelmus, Musmehl1
Plant-based foods and beverages, Plant-based foods, Condiments, Spices, Vanilla, Vanilla alcoholic extract1
Plant-based foods and beverages, Plant-based foods, Condiments, Culinary plants, Aromatic plants, Dried products, Spices, Aromatic-herbs, Dried plant-based foods, Ground dried aromatic plants, Dill, Ground dried dill, Groceries1
Aliments et boissons à base de végétaux, Boissons, Boissons chaudes, Boissons à base de végétaux, Thés, Thés noirs, Thés aromatisés, Thés noirs aromatisés, Thés au citron, Thés noirs aromatisés au citron1
Aliments et boissons à base de végétaux, Boissons, Boissons chaudes, Boissons à base de végétaux, Thés2
Produits laitiers, Produits fermentés, Desserts, Produits laitiers fermentés, Desserts lactés, Desserts lactés fermentés, Yaourts, Yaourts sans lactose1
Pflanzliche Lebensmittel und Getränke, Pflanzliche Lebensmittel, Getreide und Kartoffeln, Brote, Toastbrote1
Botanas, Snacks dulces, Galletas y pasteles, Pasteles, Pasteles de chocolate, en:chocolate-cake-with-melting-centre1
Viandes et dérivés, Civets, Civet de cerf1
Non food products, Open Beauty Facts1
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Petit-déjeuners, Céréales et pommes de terre, Céréales et dérivés, Céréales pour petit-déjeuner, Mueslis1
Pflanzliche Lebensmittel und Getränke, Pflanzliche Lebensmittel, Frucht- und gemüsebasierte Lebensmittel, Tiefkühlprodukte, Fertiggerichte, Gemüsebasierte Lebensmittel, Tiefgekühlte pflanzliche Lebensmittel, Tiefkühl-Gemüse1
Imbiss, Süßer Snack, Süßwaren, Bonbons, Dauerlutscher1
Напитки, Молочные продукты, Ферментированные пищевые продукты, Десерты, Кисломолочные продукты, Молочные десерты, Молочные напитки, en:Fermented dairy desserts, Ферментированные напитки, Кисломолочные напитки, Йогурт, Питьевые йогурты1
Dairies, Creams1
Aliments et boissons à base de végétaux, Boissons, Boissons à base de végétaux, Boissons aux fruits, Jus et nectars, Jus de fruits, Jus de fruits à base de concentré, Jus de raisin, Jus de raisin à base de concentré1
Meats and their products, Meats, Fresh meats, Fresh meat preparations1
Plant-based foods and beverages, Plant-based foods, Pastas1
Pflanzliche Lebensmittel und Getränke, Pflanzliche Lebensmittel, Imbiss, Salzige Snacks, Nüsse und Nussprodukte, Nüsse, Geröstete Nüsse, Gesalzene Nüsse, Cashewnüsse, Geröstete Cashews, Gesalzene Cashewnüsse1
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Pâtes alimentaires1
Plats préparés, Pizzas tartes salées et quiches1
Dairies, Fermented foods, Fermented milk products, Cheeses, Cow cheeses, Cheeses from the United Kingdom, Cheeses from England, Cheddar cheese1
Plant-based foods and beverages, Beverages, Hot beverages, Plant-based beverages, Teas1
Dairies, Fermented foods, Fermented milk products, Cheeses2
Dairies, Fermented foods, Fermented milk products, Cheeses, Mexican cheeses1
Fats2
Boissons1
Snacks, Snacks sucrés1
Aliments pour bébé, Laits pour bébé, Laits de croissance1
Mejeriprodukt, Fermenterad mat, Fermenterade mjölkprodukter, Ostar, Italienska ostar, en:Stretched-curd cheeses, Mozzarella1
Salaattikastikkeet1
Plant-based foods and beverages,Plant-based foods,Breakfasts,Cereals and potatoes,Cereals and their products,Breakfast cereals,Flakes,Cereal flakes,Rolled flakes,Rolled oats,Porridge1
Imbiss, Salzige Snacks, Vorspeisen, Chips und Pommes Frites, Chips1
Gewürzmittel, Saucen, Salatsoßen, en:groceries1
Gewürzmittel, Saucen, Senfe1
Condiments, Sauces, Sauces salades, en:groceries1
en:Aderezos, en:Comestibles, en:Condimentos, en:Salsas1
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Condiments, Epices, Sauces, Piments, Moutardes, Habanero, en:Groceries1
Cibi e bevande a base vegetale, Cibi a base vegetale, Colazioni, Condimenti, Spalmabili, Spalmabili a base di piante, Spalmabili dolci, Confetture e marmellate, Confetture, Salse, Confetture di agrumi, Confitture di arancia, en:Groceries, Mostarda1
cereals and their products1
Snacks, Snacks sucrés, Cacao et dérivés, Confiseries, Confiseries chocolatées, Bonbons de chocolat, Confiseries aux fruits, Fruits enrobés de chocolat1
Snacks, Snacks sucrés, Confiseries, Nougats, Nougats blancs1
céréales1
Landwirtschaftliche Produkte, Vogeleier, Hühnereier, Frische Eier1
Viandes et dérivés, Viandes, Poulet et dérivés, Préparations de viande, Volailles, Produits panés, Poulets, Volailles cuites, Préparations au poulet, Poulets cuisinés, Nuggets de volaille, Poulets panés, Nuggets de poulet1
en:Meat alternatives, Carnes vegetales, Empanados, Sustitutos de pescado empanado1
en:sausages1
Plant-based foods and beverages,Plant-based foods,Condiments,Spreads,Plant-based spreads,Salted spreads,Sauces,Dips,Hummus,Classic hummus1
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Aliments à base de fruits et de légumes, Plats préparés, Soupes, Veloutés, Soupes de légumes, Veloutés de légumes, Velouté en brique1
Dairies, Fermented foods, Fermented milk products, Creams, Fermented creams, Sour creams, fr:Crèmes fraîches1
Snacks, Salty snacks, Appetizers, Crackers2
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Petit-déjeuners, Produits à tartiner, Pâtes à tartiner végétales, Produits à tartiner sucrés, Confitures et marmelades, Confitures, Confitures de cerises1
Plant-based foods and beverages, Plant-based foods, Cereals and potatoes, Breads1
Plant-based foods and beverages, Plant-based foods, Cereals and potatoes, Cereals and their products1
Getränke, Teegetränke, Eistees1
en:grated-cheese1
Produits laitiers, Produits fermentés, Desserts, Produits laitiers fermentés, Desserts lactés, Desserts lactés fermentés, Fromages blancs1
Sandwichs, Sandwichs garnis de charcuteries, Sandwichs au jambon, Sandwichs polaires1
Sandwichs, Sandwichs à la volaille, Sandwichs au poulet, Sandwichs aux crudités1
Surgelés, Crêpes et galettes, Pancakes1
Produits laitiers, Produits fermentés, Desserts, Produits laitiers fermentés, Fromages, Desserts lactés, Desserts lactés fermentés, Petits suisses, Quarks, Fromages blancs, Fromages à la crème1
Aliments et boissons à base de végétaux,Boissons,Boissons à base de végétaux,Boissons au thé,Thés glacés,Thés glacés saveur pêche,Boissons avec sucre ajouté1
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Aliments à base de fruits et de légumes, Légumes et dérivés, Frais, Aliments à base de plantes frais, Tomates et dérivés, Légumes frais, Tomates, Tomates fraîches1
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Céréales et pommes de terre, Pains, Pains de seigle, Pains complets, Pain-de-seigle-complet, Vollkornbrot-pain-de-seigle-complet-bio1
Produits laitiers, Produits fermentés, Produits laitiers fermentés, Fromages, Surgelés, Fromages de vache, Frais, Fromages à pâte molle à croûte fleurie, Camemberts, Camemberts au lait de vache, Fromages de France, Fromages au lait cru, Camemberts au lait1
Produits laitiers, Produits fermentés, Produits laitiers fermentés, Fromages, Fromages de vache, Fromages de France, Fromages à pâte pressée non cuite, Mimolettes, Mimolettes vieilles, Fromages-du-nord-pas-de-calais1
Produits laitiers, Produits fermentés, Produits laitiers fermentés, Fromages, Fromages de France, Fromages à pâte pressée non cuite, Fromages de brebis, Ossau-Iraty1
Produits de la mer,Poissons et dérivés,Poissons,Poissons gras,Saumons,Poissons fumés,Saumons fumés,Saumons fumés d'élevage1
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Graines, Produits de la plante de courge, Graines de cucurbitacées, Graines de courge et dérivés, Graines de courge1
Desserts, Surgelés, Desserts glacés, Glaces et sorbets, Sorbets, Sorbets à la fraise1
Imbiss, Süßer Snack, Riegel1
Nahrungsergänzungsmittel, Nahrungsergänzungen für Bodybuilder, Proteinpulver, Proteinshakes1
Aliments et boissons à base de végétaux, Boissons, Boissons à base de végétaux1
Meals, Pizzas pies and quiches, Pizzas1
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Céréales et pommes de terre, Céréales et dérivés, Pâtes alimentaires1
Aliments et boissons à base de végétaux, Aliments d'origine végétale, Céréales et pommes de terre, Céréales et dérivés, Pâtes alimentaires, Pâtes alimentaires de céréales, Pâtes sèches, Pâtes de blé dur, Penne de blé dur, Penne, Penne Rigate1
Lácteos, Leches, Leche entera1
Snacks1
Meals,Soups1
en:pasta-salads1
Condiments, Dried products, Dried products to be rehydrated, Broths, Dehydrated broths, Bouillon cubes, Groceries1
Snacks, Snacks sucrés, Confiseries, Surgelés, Bonbons1
Plant-based foods and beverages,Plant-based foods,Cereals and potatoes,Seeds,Cereals and their products,Cereal grains,Rices1
Plant-based foods and beverages, Plant-based foods, Breakfasts, Spreads, Plant-based spreads, Sweet spreads, Fruit and vegetable preserves1
Plant-based foods and beverages, Plant-based foods, Spreads, Plant-based spreads, en:salted-spreads1
Alternatives à la viande, Substituts de viande, Galettes végétariennes, Galettes véganes1
en:Meals, en:Pasta dishes, en:Prepared lasagne1
Dairies, Milks, Semi-skimmed milks, Pasteurised milks, Cow milks, Semi-skimmed pasteurised milk1
Broths1
Слойка, Слойка с сыром, Хачапури1
Beauty & Personal Care1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Assorted flavors hearts, watermelon, strawberry lemonade, fruit punchSnacks, Sweet snacks, Confectioneriesmalic acid2024-02-12
Cheddar mashed potatoesOtherlactic acid,beta carotene2024-02-11
Fajita style tortillasMexican Dinner Mixessodium bicarbonate,niacin2024-02-12
Golden pepperoniSalted snackssodium bisulfite2024-02-12
Milk chocolate with peanuts & raisinsSnacks, Sweet snacks, Cocoa and its products, Confectioneries, Chocolate candieslactose2024-02-11
Sour punch strawberry sour straws trayAmerican Licorice CompanySnacks, Sweet snacks, Confectioneriesmalic acid2024-02-09
Imitation VanillaBadiaPlant-based foods and beverages, Plant-based foods, Condiments, Spices, Vanilla, Vanilla alcoholic extractvanillin2024-02-11
Cell Intense CienCienNon food products, Open Beauty FactsDibutyl Adipate2024-02-13
Darigold, mexican style sour creamDarigoldDairies, Creamscalcium sulfate2024-02-09
Breakfast packDonald & sonsMeats and their products, Meats, Fresh meats, Fresh meat preparationsNiacin2024-02-14
Cracker Cut Sharp Cheddar CheeseGiant EagleDairies, Fermented foods, Fermented milk products, Cheeses, Cow cheeses, Cheeses from the United Kingdom, Cheeses from England, Cheddar cheeseannatto2024-02-09
Fancy ShreddedGiant Eagle, Giant Eagle Inc.Dairies, Fermented foods, Fermented milk products, Cheesesannatto,natamycin2024-02-09
Spreadable Butter With Canola OilGold'N SoftFatslactic acid2024-02-09
Essential M, Toasted Rice CerealMeijerOtherniacinamide2024-02-09
Palermo's, classics, thin crust pepperoni pizzaPalermo's, Palarmo Villa Inc.Meals, Pizzas pies and quiches, Pizzassodium bicarbonate2024-02-09
Gourmet Rosemary Savoury CrackersSpecially SelectedSnacks, Salty snacks, Appetizers, CrackersNiacin,Riboflavin2024-08-31
Eucerin Skin Calming Body Wash Fragrance Free -- 8.4 fl ozEucerinBeauty & Personal Carelaureth-4, laureth-4, laureth-9, propyl gallate, propylene glycol2024-11-29 10:47:42

Drug Classes (1)

ClassDescription
trihydroxybenzoic acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (32)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency66.96230.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency33.18920.006038.004119,952.5996AID1159521; AID1159523
SMAD family member 2Homo sapiens (human)Potency19.40080.173734.304761.8120AID1346859
GLS proteinHomo sapiens (human)Potency28.18380.35487.935539.8107AID624170
SMAD family member 3Homo sapiens (human)Potency19.40080.173734.304761.8120AID1346859
TDP1 proteinHomo sapiens (human)Potency26.78520.000811.382244.6684AID686978; AID686979
GLI family zinc finger 3Homo sapiens (human)Potency13.56910.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency8.42030.000221.22318,912.5098AID588515; AID743035; AID743036; AID743063
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency9.11620.001022.650876.6163AID1224838; AID1224839; AID1224893
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency1.69330.01237.983543.2770AID1645841
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency5.45240.000214.376460.0339AID588533; AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency8.77750.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency23.15310.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency27.64250.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency50.76880.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency23.04570.000229.305416,493.5996AID588513; AID588514; AID743069; AID743075; AID743077; AID743078; AID743079
cytochrome P450 2D6Homo sapiens (human)Potency23.91850.00108.379861.1304AID1645840
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency11.22020.001024.504861.6448AID588534
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency17.37390.001019.414170.9645AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency61.35080.023723.228263.5986AID743222
aryl hydrocarbon receptorHomo sapiens (human)Potency13.60570.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency23.90690.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency68.24100.001628.015177.1139AID1224843
activating transcription factor 6Homo sapiens (human)Potency0.34670.143427.612159.8106AID1159516
Histone H2A.xCricetulus griseus (Chinese hamster)Potency62.61070.039147.5451146.8240AID1224845; AID1224896
Caspase-7Cricetulus griseus (Chinese hamster)Potency68.58960.006723.496068.5896AID1346980
caspase-3Cricetulus griseus (Chinese hamster)Potency68.58960.006723.496068.5896AID1346980
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency6.82190.000323.4451159.6830AID743065; AID743066; AID743067
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency18.29590.000627.21521,122.0200AID651741; AID720636; AID743202; AID743219
Cellular tumor antigen p53Homo sapiens (human)Potency42.50460.002319.595674.0614AID651631
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Xanthine dehydrogenase/oxidaseHomo sapiens (human)IC50 (µMol)628.00000.00132.81389.8200AID378145
Anthrax toxin receptor 2Homo sapiens (human)IC50 (µMol)300.00000.30000.45350.6070AID725981
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (150)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
allantoin metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of protein phosphorylationXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell proliferationXanthine dehydrogenase/oxidaseHomo sapiens (human)
guanine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
inosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyinosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
adenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyadenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyguanosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
AMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
IMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
lactationXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of gene expressionXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron-sulfur cluster assemblyXanthine dehydrogenase/oxidaseHomo sapiens (human)
amide catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell differentiationXanthine dehydrogenase/oxidaseHomo sapiens (human)
GMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dGMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dAMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of p38MAPK cascadeXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vascular endothelial growth factor signaling pathwayXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of reactive oxygen species metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vasculogenesisXanthine dehydrogenase/oxidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (46)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron ion bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein homodimerization activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
FAD bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein bindingAnthrax toxin receptor 2Homo sapiens (human)
metal ion bindingAnthrax toxin receptor 2Homo sapiens (human)
transmembrane signaling receptor activityAnthrax toxin receptor 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (27)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
peroxisomeXanthine dehydrogenase/oxidaseHomo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
sarcoplasmic reticulumXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular regionAnthrax toxin receptor 2Homo sapiens (human)
endoplasmic reticulum membraneAnthrax toxin receptor 2Homo sapiens (human)
plasma membraneAnthrax toxin receptor 2Homo sapiens (human)
endosome membraneAnthrax toxin receptor 2Homo sapiens (human)
plasma membraneAnthrax toxin receptor 2Homo sapiens (human)
cell surfaceAnthrax toxin receptor 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (98)

Assay IDTitleYearJournalArticle
AID335901Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2002Journal of natural products, Sep, Volume: 65, Issue:9
Oxidation, reduction, and methylation of carnosic acid by Nocardia.
AID207502Inhibitory activity against Staphylococcus aureus (MRSA) was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID202862Antifungicidal activity against Saccharomyces cerevisiae was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID195249Inhibition of microsomal lipid peroxidation induced by [Fe(3+)]-ADP/NADPH at 100 uM concentration in rat liver1995Journal of medicinal chemistry, Jul-07, Volume: 38, Issue:14
Synthesis and pharmacological evaluation of 2'-hydroxychalcones and flavones as inhibitors of inflammatory mediators generation.
AID617266Radioprotective activity against 0 to 7 Gy gamma radiation-induced death in mouse 32Dcl3 cells at 10 uM treated 1 hr prior to irradiation after 7 days by microscopy2011ACS medicinal chemistry letters, Jan-25, Volume: 2, Issue:4
The Use of 3,5,4'-Tri-O-acetylresveratrol as a Potential Pro-drug for Resveratrol Protects Mice from γ-Irradiation-Induced Death.
AID164232Antimicrobial activity against Pseudomonas aeruginosa was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID417963Antimicrobial activity against Aspergillus fumigatus after 48 hrs by broth microdilution technique2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi.
AID1179805Antioxidant activity assessed as ABTS+ radical scavenging capacity after 16 hrs by UV spectrophotometry2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Antioxidant effects of the highly-substituted carbazole alkaloids and their related carbazoles.
AID202863Inhibitory activity against Saccharomyces cerevisiae was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID195240Inhibition of microsomal lipid peroxidation induced by [Fe(2+)]/ascorbate in rat liver1995Journal of medicinal chemistry, Jul-07, Volume: 38, Issue:14
Synthesis and pharmacological evaluation of 2'-hydroxychalcones and flavones as inhibitors of inflammatory mediators generation.
AID725981Inhibition of CMG2 (40 to 217) C175A and R40C double mutant (unknown origin) interaction to full length PA E733C mutant expressed in Escherichia coli by FRET assay2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose inhibits angiogenesis via inhibition of capillary morphogenesis gene 2.
AID624609Specific activity of expressed human recombinant UGT1A62000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID401336Antioxidant activity assessed by superoxide anion scavenging assay1996Journal of natural products, Feb, Volume: 59, Issue:2
Natural polyphenols (vegetable tannins) as drugs: possible modes of action.
AID69026Inhibitory activity against Escherichia coli was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID197786Compound was evaluated for the inhibition of recombinant HIV-1 reverse transcriptase; No data2000Bioorganic & medicinal chemistry letters, Jan-03, Volume: 10, Issue:1
Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity.
AID43627Antimicrobial activity against Brevibacterium ammoniagenes was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID163210Antimicrobial activity against Proteus vulgaris was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID123063Inhibitory activity against Micrococcus luteus was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID206847Antimicrobial activity against Staphylococcus aureus was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID536654Antioxidant activity assessed as Superoxide anion radical scavenging activity in cell-free system2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives.
AID624606Specific activity of expressed human recombinant UGT1A12000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID67846Inhibitory activity against Enterobacter aerogenes was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID47595Inhibitory activity against Candida albicans was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID732057Cytotoxicity against human HeLa cells2013European journal of medicinal chemistry, Feb, Volume: 60Alkyl esters of gallic acid as anticancer agents: a review.
AID417969Antimicrobial activity against Trichophyton mentagrophytes after 48 hrs by broth microdilution technique2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi.
AID289317Superoxide radical scavenging activity by NBT reduction assay2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species.
AID67546Antimicrobial activity against Enterobacter aerogenes was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID220440Inhibitory activity against Zygosaccharomyces bailii was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID624610Specific activity of expressed human recombinant UGT1A72000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID206730Antimicrobial activity against Staphylococcus aureus (MRSA) was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID163400Inhibitory activity against Proteus vulgaris was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID209599Antimicrobial activity against Streptococcus mutans was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID40641Antimicrobial activity against Bacillus subtilis was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID732053Cytotoxicity against mouse WEHI231 cells2013European journal of medicinal chemistry, Feb, Volume: 60Alkyl esters of gallic acid as anticancer agents: a review.
AID732052Cytotoxicity against mouse L929 cells2013European journal of medicinal chemistry, Feb, Volume: 60Alkyl esters of gallic acid as anticancer agents: a review.
AID1101855Antifungal activity against Saccharomyces cerevisiae ATCC 7754 after 48 hr by microdilution method2002Journal of agricultural and food chemistry, Jul-03, Volume: 50, Issue:14
Molecular design of antifungal agents.
AID205640Compound was tested for antibacterial activity against MRSA ATCC 33591, expressed as minimum inhibitory concentration (MIC)2002Bioorganic & medicinal chemistry letters, Jan-21, Volume: 12, Issue:2
Anti-MRSA activity of alkyl gallates.
AID160377Antimicrobial activity against Propionibacterium acnes was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID417960Antifungal activity against Candida tropicalis after 48 hrs by broth microdilution technique2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi.
AID69600Antimicrobial activity against Escherichia coli was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID745547Antioxidant activity of the compound assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry2013European journal of medicinal chemistry, May, Volume: 63Triazolothiadiazoles and triazolothiadiazines--biologically attractive scaffolds.
AID159273percent inhibition of 2,2'-azobis(2-amidinopropane)dihydrochloride induced decay of (R)-phycoerythrin fluorescence emission1993Journal of medicinal chemistry, Apr-30, Volume: 36, Issue:9
Benzylamine antioxidants: relationship between structure, peroxyl radical scavenging, lipid peroxidation inhibition, and cytoprotection.
AID417966Antimicrobial activity against Microsporum gypseum after 48 hrs by broth microdilution technique2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi.
AID417967Antimicrobial activity against Epidermophyton floccosum after 48 hrs by broth microdilution technique2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi.
AID1185949Antioxidant activity assessed as superoxide anion radical scavenging activity by nitroblue tetrazolium method2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities.
AID200491Inhibitory activity against Salmonella choleraesuis was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID207503Inhibitory activity against Staphylococcus aureus was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID195236IC50 value was evaluated by measuring the 50% inhibition of peroxyl scavenging activity.1995Journal of medicinal chemistry, Jul-07, Volume: 38, Issue:14
Synthesis and pharmacological evaluation of 2'-hydroxychalcones and flavones as inhibitors of inflammatory mediators generation.
AID378144Antioxidant activity assessed as DPPH radical scavenging activity2005Journal of natural products, Feb, Volume: 68, Issue:2
Bioactive constituents from Boswellia papyrifera.
AID417968Antimicrobial activity against Trichophyton rubrum after 48 hrs by broth microdilution technique2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi.
AID228862Antioxidant activity was evaluated by measuring the inhibition of oxidation of ABTS to ABTS+ by metmyoglobin in the presence of H2O2.2000Bioorganic & medicinal chemistry letters, Jan-03, Volume: 10, Issue:1
Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity.
AID688738Antioxidant activity in bovine brain assessed as inhibition of iron-ascorbate-induced lipid peroxidation at 100 uM by thiobarbituric acid test2012Bioorganic & medicinal chemistry, Oct-01, Volume: 20, Issue:19
Design and synthesis of EGFR dimerization inhibitors and evaluation of their potential in the treatment of psoriasis.
AID401337Antioxidant activity assessed by hydroxyl radical scavenging assay1996Journal of natural products, Feb, Volume: 59, Issue:2
Natural polyphenols (vegetable tannins) as drugs: possible modes of action.
AID448784Antioxidant activity assessed as superoxide radical scavenging activity at 0.5 mM by NBT reduction assay2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Anti-oxidant, anti-fungal and anti-leishmanial activities of novel 3-[4-(1H-imidazol-1-yl) phenyl]prop-2-en-1-ones.
AID195245Inhibition of microsomal lipid peroxidation induced by CCl4/NADPH in rat liver1995Journal of medicinal chemistry, Jul-07, Volume: 38, Issue:14
Synthesis and pharmacological evaluation of 2'-hydroxychalcones and flavones as inhibitors of inflammatory mediators generation.
AID162793Inhibitory activity against Pseudomonas aeruginosa was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID443281Antioxidant activity assessed as superoxide radical scavenging activity measured as formazone formation by spectrophotometry relative to control2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Anti-oxidant and anti-bacterial activities of novel N'-arylmethylidene-2-(3, 4-dimethyl-5, 5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-2(4H)-yl) acetohydrazides.
AID200352Antimicrobial activity against Salmonella choleraesuis was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID40644Inhibitory activity against Bacillus subtilis was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID624612Specific activity of expressed human recombinant UGT1A92000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID417959Antifungal activity against Candida albicans after 48 hrs by broth microdilution technique2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi.
AID1185948Antioxidant activity assessed as DPPH free radical scavenging activity incubated at 37 degC for 30 mins by microtiter plate reader based method2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities.
AID195247Inhibition of microsomal lipid peroxidation induced by [Fe(2+)]/ascorbate at given 100 uM concentration in rat liver1995Journal of medicinal chemistry, Jul-07, Volume: 38, Issue:14
Synthesis and pharmacological evaluation of 2'-hydroxychalcones and flavones as inhibitors of inflammatory mediators generation.
AID47577Antifungicidal activity against Candida albicans was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID122914Antimicrobial activity against Micrococcus luteus was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID144633The compound was evaluated for percent reduction of H2O2-induced H2DCFDA fluorescence in NALM-6-B-cells;No data2000Bioorganic & medicinal chemistry letters, Jan-03, Volume: 10, Issue:1
Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity.
AID378145Inhibition of xanthine oxidase2005Journal of natural products, Feb, Volume: 68, Issue:2
Bioactive constituents from Boswellia papyrifera.
AID37581Antifungicidal activity against Aspergillus niger was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID209712Inhibitory activity against Streptococcus mutans was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID37582Inhibitory activity against Aspergillus niger was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID43630Inhibitory activity against Brevibacterium ammoniagenes was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID195257Percent inhibition was evaluated by measuring the inhibition of peroxyl scavenging activity at 100 uM concentration1995Journal of medicinal chemistry, Jul-07, Volume: 38, Issue:14
Synthesis and pharmacological evaluation of 2'-hydroxychalcones and flavones as inhibitors of inflammatory mediators generation.
AID536653Antioxidant activity assessed as DPPH free radical scavenging activity in cell-free system after 30 mins2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives.
AID78013Antioxidative activity was evaluated by using the lipid peroxidation of guinea pig liver microsomes1999Bioorganic & medicinal chemistry letters, Apr-05, Volume: 9, Issue:7
Total synthesis of an antioxidant isolated from yeast via palladium-catalyzed coupling and its application for related compounds.
AID1179804Antioxidant activity assessed as DPPH radical scavenging capacity after 30 mins by UV spectrophotometry2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Antioxidant effects of the highly-substituted carbazole alkaloids and their related carbazoles.
AID417965Antimicrobial activity against Aspergillus niger after 48 hrs by broth microdilution technique2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi.
AID624613Specific activity of expressed human recombinant UGT1A102000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID195238Inhibition of microsomal lipid peroxidation induced by CCl4/NADPH in rat liver1995Journal of medicinal chemistry, Jul-07, Volume: 38, Issue:14
Synthesis and pharmacological evaluation of 2'-hydroxychalcones and flavones as inhibitors of inflammatory mediators generation.
AID226123Inhibitory activity against Propionibacterium acnes was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID206848Compound was tested for antibacterial activity against MRSA ATCC 33591, expressed as minimum bactericidal concentration (MBC)2002Bioorganic & medicinal chemistry letters, Jan-21, Volume: 12, Issue:2
Anti-MRSA activity of alkyl gallates.
AID1055727Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2013European journal of medicinal chemistry, , Volume: 70Solution-phase microwave assisted parallel synthesis of N,N'-disubstituted thioureas derived from benzoic acid: biological evaluation and molecular docking studies.
AID1873184Antioxidant activity assessed as inhibition of DPPH radical scavenging activity by measuring reduction in absorbance at 100 uM by spectrophotometric analysis relative to control2022European journal of medicinal chemistry, Jul-05, Volume: 237Occurrence, synthesis and biological activity of 2-(2-phenyethyl)chromones.
AID417961Antifungal activity against Saccharomyces cerevisiae after 48 hrs by broth microdilution technique2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi.
AID45822The compound was evaluated for percent reduction of H2O2-induced H2DCFDA fluorescence in human CEM T-cells;No data2000Bioorganic & medicinal chemistry letters, Jan-03, Volume: 10, Issue:1
Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity.
AID195241Inhibition of microsomal lipid peroxidation induced by [Fe(3+)]-ADP/NADPH in rat liver1995Journal of medicinal chemistry, Jul-07, Volume: 38, Issue:14
Synthesis and pharmacological evaluation of 2'-hydroxychalcones and flavones as inhibitors of inflammatory mediators generation.
AID468431Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2009Journal of natural products, Oct, Volume: 72, Issue:10
Lipocarbazoles, secondary metabolites from Tsukamurella pseudospumae Acta 1857 with antioxidative activity.
AID417962Antifungal activity against Cryptococcus neoformans after 48 hrs by broth microdilution technique2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi.
AID401338Antioxidant activity assessed by singlet oxygen scavenging assay1996Journal of natural products, Feb, Volume: 59, Issue:2
Natural polyphenols (vegetable tannins) as drugs: possible modes of action.
AID1179807Cytotoxicity against human HCT116 cells assessed as reduction cell viability at 100 uM after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Antioxidant effects of the highly-substituted carbazole alkaloids and their related carbazoles.
AID732060Cytotoxicity against human HL60 cells2013European journal of medicinal chemistry, Feb, Volume: 60Alkyl esters of gallic acid as anticancer agents: a review.
AID220439Antifungicidal activity against Zygosaccharomyces bailii was determined2001Bioorganic & medicinal chemistry letters, Feb-12, Volume: 11, Issue:3
Antifungal activity of octyl gallate: structural criteria and mode of action.
AID417964Antimicrobial activity against Aspergillus flavus after 48 hrs by broth microdilution technique2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi.
AID1179806Antioxidant activity assessed as reduction of Cu2+ to Cu+ after 3 mins by PAO-SO method2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Antioxidant effects of the highly-substituted carbazole alkaloids and their related carbazoles.
AID165766Inhibition of iron-dependent peroxidation of rabbit vesicular membrane lipids (minimum test concentration that gave greater than 50% inhibition).1993Journal of medicinal chemistry, Apr-30, Volume: 36, Issue:9
Benzylamine antioxidants: relationship between structure, peroxyl radical scavenging, lipid peroxidation inhibition, and cytoprotection.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (439)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990107 (24.37)18.7374
1990's85 (19.36)18.2507
2000's114 (25.97)29.6817
2010's106 (24.15)24.3611
2020's27 (6.15)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 54.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index54.92 (24.57)
Research Supply Index6.16 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index91.63 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (54.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (0.64%)5.53%
Reviews17 (3.62%)6.00%
Case Studies20 (4.26%)4.05%
Observational0 (0.00%)0.25%
Other429 (91.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Single Dose LY2484595 Tablet Formulations to Determine the Impact of Dose Level, Food, and Ethnicity on the Pharmacokinetics in Healthy Subjects [NCT01450098]Phase 139 participants (Actual)Interventional2011-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT01450098 (3) [back to overview]Number of Participants With One or More Drug-related Adverse Events (AEs) or Any Serious AEs
NCT01450098 (3) [back to overview]Pharmacokinetics: Area Under the Plasma Concentration Versus Time Curve (AUC) of LY2484595
NCT01450098 (3) [back to overview]Pharmacokinetics: Peak Plasma Concentration (Cmax) of LY2484595
[back to top]

Pharmacokinetics: Area Under the Plasma Concentration Versus Time Curve (AUC) of LY2484595

Area under the concentration-time curve from time zero to infinity is presented. (NCT01450098)
Timeframe: Predose and 1, 2, 3, 4, 6, 8, 12, 24, 48, 72, and 168 hours postdose

Interventionhours times nanograms per milliliter (Geometric Mean)
LY2484595 200 mg SDSD-PG Fasted12200
LY2484595 200 mg SDSD-PG Low Fat17800
LY2484595 200 mg SDSD-PG High Fat17800

[back to top]

Pharmacokinetics: Peak Plasma Concentration (Cmax) of LY2484595

(NCT01450098)
Timeframe: Predose and 1, 2, 3, 4, 6, 8, 12, 24, 48, 72, and 168 hours postdose

Interventionnanograms per milliliter (Geometric Mean)
LY2484595 200 mg SDSD-PG Fasted828
LY2484595 200 mg SDSD-PG Low Fat1510
LY2484595 200 mg SDSD-PG High Fat1280

[back to top]